Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

NCT01380106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide 15mg
DRUG: Lenalidomide 25mg

Sponsor

Boston VA Research Institute, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]